GW Pharmaceuticals PLC Sponsored ADR
(NASDAQ : GWPH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
1.66%93.3518.6%$149.99m
AMRNAmarin Corporation Plc Sponsored ADR
14.00%19.872.0%$137.64m
SAGESAGE Therapeutics, Inc.
5.33%153.979.5%$73.78m
JAZZJazz Pharmaceuticals Plc
0.64%126.012.2%$73.23m
PRGOPerrigo Co. Plc
1.30%48.956.8%$61.62m
GWPHGW Pharmaceuticals PLC Sponsored ADR
5.31%151.606.3%$58.36m
CTLTCatalent Inc
2.45%43.582.4%$42.91m
PTLAPortola Pharmaceuticals, Inc.
2.85%31.017.7%$42.60m
ICLRICON Plc
2.14%145.194.1%$35.73m
HZNPHorizon Pharma plc
-0.19%21.207.4%$30.70m
CORTCorcept Therapeutics Incorporated.
2.80%11.405.5%$30.30m
AERIAerie Pharmaceuticals, Inc.
3.46%40.046.9%$28.49m
UTHRUnited Therapeutics Corporation
1.09%118.3014.4%$27.96m
MDCOMedicines Company
1.84%24.3421.8%$26.60m
MNKMallinckrodt Plc
4.75%21.5021.1%$26.07m

Company Profile

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.